IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q3 2024 Holdings

Filed 2024-11-13 | 4 holdings | $227.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biohaven LTD(BHVN)COMG1110E107$146.7M2,936,50764.4%
Cytokinetics, Inc(CYTK)COM23282W605$51.8M980,39222.7%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$29.2M3,846,15412.8%
Viracta Therapeutics IncCOM92765F108$8513,7000.0%